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Glomerular hemodynamics in experimental diabetes mellitus.
Micropuncture studies were performed in three groups of eu-
volemic male Munich-Wistar rats: 8 control rats, 7 severely hy-
perglycemic rats made diabetic with streptozotocin (60 mg/kg,
i.v.), and 6 moderately hyperglycemic rats made diabetic by the
same method but given 2 U of NPH insulin daily. Glucose con-
centrations at the time of micropuncture study averaged 115
(sEM) 10, 565 12, and 375 23 mgldl, respectively. Single
nephron GFR (SNGFR) values were significantly lower (28.8
1.9 nllmin) in severely hyperglycemic rats than they were in con-
trols (48.9 3.8). This reduction in SNGFR was due mainly to a
fall in glomerular plasma flow rate (QA). In contrast, moderately
hyperglycemic rats exhibited glomerular hyperfiltration, with
SNGFR values averaging 69.0 8.0 nI/mm. This hyperfiltration
resulted from elevations in values for QA and glomerular trans-
capillary hydraulic pressure difference (iSP) to levels significant-
ly above control. These alterations in SNGFR in severely hyper-
glycemic and moderately hyperglycemic rats, relative to con-
trols, were paralleled by changes in whole kidney GFR and
mimic the changes in GFR observed in diabetic patients with
analogous degrees of hyperglycemia. Measurements of blood
volumes in separate groups of control, severely, and moderately
hyperglycemic rats revealed equivalent absolute blood volumes
in all three conditions and increased blood volumes, relative to
body weight, in both groups of hyperglycemic rats. Thus,
SNGFR is increased in diabetic rats with moderate hyper-
glycemia but decreased in those with severe hyperglycemia, and
these changes are not simply related to variations in circulating
blood volume.
Hémodynamique glomerulaire dans le diabéte sucré ex-
périmental. Des microponctions ont été réalisées dans trois
groupes de rats Munich-Wistar euvolémiques: 8 rats contrôles, 7
rats très hyperglycémiques atteints de diabète déterminé par Ia
streptozotocyne (60 mg/kg, i.v.), et 6 rats modérément hyper-
glycémiques rendus diabétiques par Ia méme méthode mais qui
recevaient deux unites d'insuline NPH par jour. Les concentra-
tions de glucose au moment des microponctions étaient en
moyenne de 115 (sEM) 10,565 12, et 375 23 mg/dl, respec-
tivement. Les valeurs de debits de filtration glomérulaire individ-
uels (SNGFR) étaient significativement inférieures (28,8 1,9
nI/mm) chez les rats sévèrement hyperglycémiques par rapport
aux contrôles (48,9 3,8). Cette reduction de SNGFR était sur-
tout due a une chute du debit plasmatique glomérulaire (QA). Au
contraire, les rats modérément hyperglycémiques avaient une
hyperfiltration glomérulaire avec des valeurs en moyenne de 69,0
8,0 nI/mm. Cette hyperfiltration était Ia consequence de Va-
leurs de QA et de Ia difference de pression hydraulique trans-
capillaire glomerulaire (P) a des niveaux significativement su-
perieurs aux contrdles. Ces modifications de SNGFR chez les rats
sévèrement et modérément hyperglycémiques, par rapport aux
contrôles, étaient reflétées par des modifications du debit de fil-
tration glomérulaire, GFR, et reproduisent les modifications de
GFR observées chez ces malades diabétiques ayant des degrés
semblables d'hyperglycémie. La mesure du volume sanguin dans
des groupes contrôles différents, sévèrement et modérément hy-
perglycémiques, a montré des volumes absolus equivalents dans
les trois situations et des volumes augmentés par rapport au
poids corporel dans les deux groupes de rats hyperglycémiques.
Ainsi SNGFR est augmente chez les rats diabétiques mode-
rement hyperglycemiques, mais diminue chez ceux qui sont
sévèrement hyperglycémiques et ces modifications ne sont pas
seulement en rapport avec des variations du volume sanguin cir-
culant.
Several lines of evidence indicate that renal he-
modynamics are altered in clinical and experimental
diabetes mellitus, and that changes in renal hemo-
dynamics play a role in the pathogenesis of the ne-
phropathy commonly seen in this metabolic dis-
order [1—5]. For example, the renal lesion that de-
velops in diabetic rats may be hastened in its
progression by prior unilateral nephrectomy or ex-
posure to two-kidney Goldblatt hypertension [4, 5].
Moreover, numerous studies have documented a
consistent increase in glomerular filtration rate
(GFR) in early juvenile onset diabetes during peri-
ods of poor metabolic control [1]. Conversely,
when hyperglycemia is more severe, as in diabetic
keto-acidosis, hyperfiltration no longer occurs [2].
Thus, because of the potential importance of altera-
tions in renal microcirculatory dynamics to these
functional responses of the glomerulus in diabetes,
we investigated the hemodynamic determinants of
GFR at a relatively early stage of experimental dia-
betes induced in Munich-Wistar rats.
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Methods
Micropuncture studies were performed on 21
adult male Munich-Wistar rats, each weighing 185
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to 315 g and having free access to water and a stan-
dard rat pellet diet. Three groups of rats were stud-
ied: control, 8 normal rats; severe hyperglycemia, 7
rats given streptozotocin (60 mg/kg, i.v.) in citrate
buffer; moderate hyperglycemia, 6 rats made dia-
betic in the same fashion but given 2 U of NPH in-
sulin s.c. each evening for at least 3 weeks prior to
study. Diabetic rats were studied 2 to 15 weeks after
streptozotocin administration (mean, 74 9 days).
All diabetic animals were glycosuric. By semi-
quantitative testing (Multistix®, Ames Company),
severely hyperglycemic rats demonstrated 3 to 4+
urine glucose; and moderately hyperglycemic ani-
mals, ito 2+.
On the morning of micropuncture study, rats
were anesthetized with mactin® (100 mg/kg body
weight, i.p.). They were prepared in standard fash-
ion for micropuncture [6] and given isoncotic rat
plasma equal to 1% of body wt i.v. to replace surgi-
cal losses [7]. Normal rats received plasma obtained
from nondiabetic donors, and diabetic rats received
plasma from diabetic donors. Plasma glucose con-
centration was measured at the beginning of each
micropuncture experiment, using a Beckman glu-
cose analyzer (model 2, Beckman Instruments,
Inc., Fullerton, California). Samples of proximal
tubular fluid were obtained by micropuncture for
determination of flow rate and inulin concentration
by the method of Vurek and Pegram [8]. Samples of
tubular fluid obtained from 2 diabetic animals prior
to inulin administration showed fluorescence equal
to the blank, indicating that there is no interference
with this assay by some substance(s) peculiar to the
diabetic state. Efferent arteriolar blood samples
were obtained by measurement of total protein con-
centration [9]. Hydraulic pressure measurements
were made in cortical tubules and vessels by the
servo-null micropipette technique [6]. The details of
the calculations used are given elsewhere [6].
In a separate group of 17 rats, measurements of
blood volume were made by the method of Sterling
and Gray [10] with 51Cr-labeled rat red blood cells.
Rats were studied under the same three metabolic
conditions as described above. These rats were
studied after 4 to 6 weeks of diabetes and 3 to 5
weeks of insulin administration. Statistical analyses
were performed by the paired or unpaired Student's
t test as appropriate. Statistical significance was de-
fined as P < 0.05.
Results
Plasma glucose concentrations at the time of mi-
cropuncture averaged 115 10, 565 12, and 375
23 mg/dl (means SEM) in normal, severely, and
moderately hyperglycemic rats, respectively. Rats
with severe hyperglycemia had significantly lower
body weights than either control (P < 0.05) or mod-
erately hyperglycemic rats (P < 0.005), but the latter
two groups demonstrated no statistically significant
difference in body weight. Mean values for whole
kidney GFR, fernoral arterial pressure (AP),
SNGFR, and determinants of SNGFR are summa-
rized in Table 1. Whole kidney GFR averaged 1.10
0.06 in control rats and 0.76 0.03 mllmin in the
severely hyperglycemic group. Values for SNGFR
paralleled this whole kidney GFR trend, averaging
48.9 3.8 and 28.8 1.9 nl/min in control and se-
verely hyperglycemic groups, respectively. On av-
erage, the mean transmembrane hydraulic pressure
difference (iSP) did not differ significantly between
the groups and thus did not account for the mea-
sured differences in GFR and SNGFR. Similarly,
there were no statistically significant differences in
afferent arteriolar protein concentrations (CA) be-
tween these groups.
The glomerular ultrafiltration coefficient (K1) was
lower, on average, in severely hyperglycemic rats
than it was in controls (Table 1). This difference po-
tentially accounts for a portion of the lower SNGFR
in the severely hyperglycemic group. Because both
control and severely hyperglycemic rats were, how-
ever, in filtration pressure equilibrium, with no sta-
tistical difference between efferent arteriolar colloid
osmotic pressure (lIE) and P in either group (P>
0.2), only minimal values for Kf may be calculated.
Thus, it is not possible to state with certainty that
the lower average minimum is truly less than the
higher. In any case, the lower value for SNGFR in
the severely hyperglycemic group can be largely ex-
plained by the lower values for initial glomerular
plasma flow rate (QA) in the severely hyperglycemic
group, averaging 86 8 nI/mm compared with 142
11 nl/min (P < 0.05) in controls.
Moderately hyperglycemic rats showed impor-
tant differences from the above in their pattern of
glomerular hemodynamics. In this group, both
whole kidney GFR and SNGFR averaged signifi-
cantly higher than they did in control or severely
hyperglycemic animals (1.47 0.13 mllmin and 69
8 nlJmin). But, GFR per gram of kidney weight
was not different in this group from control values
due to the increase in kidney weight in moderately
hyperglycemic rats. The hyperfiltration could be at-
tributed to two factors. First, QA was increased to
240 34 nllmin, a value significantly higher than in
either of the other groups studied (Table 1). Second,
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Control(N8) 247 1.14 115 45 103 47.5 12.3 35.2 17.6
Severehyperglycemia 221 1.27 565 45 102 47.7 11.2 36.6 17.2
(N= 7) ±8 ±0.06 ±12 ±1 ±4 ±1.5 ±0.3 ±1.5 ±0.8
Moderate hyperglycemia 272 1.49 375 45 114 56.4 12.0 44.4 17.6(N = 6) ±13 ±0.06 ±23 ±1 ±5 ±1.9 ±0.6 ±1.6 ±1.0
P, control vs. severe <0.05 NS <0.001 NS NS NS <0.005 NS NS
hyperglycemia
P. severe hyperglycemia vs. <0.005 <0.05 <0.001 NS NS <0.005 NS <0.005 NS
moderate hyperglycemia
P, control vs. moderate NS <0.02 <0.001 NS NS <0.005 NS <0.005 NS
hyperglycemia
Values are the means ± SEM. Abbreviations are defined as follows: AP, mean femoral arterial pressure; PGC, mean glomerular capil-
lary hydraulic pressure; PT, proximal tubular hydraulic pressure; P, mean transmembrane hydraulic pressure difference (PGC — P1); PE,
efferent arteriolar hydraulic pressure; CA and CE, afferent and efferent arteriolar protein concentration; IIAand "E, afferent and efferent
arteriolar colloid osmotic pressure; SNFF, single nephron filtration fraction; SNGFR, single nephron glomerular filtration rate; QA,
initial glomerular plasma flow rate; RA, RE, and RT, afferent, efferent, and total arteriolar resistance to blood flow; Kf, glomerular ultra-
filtration coefficient.
the mean value of &Pwas also significantly higher,
due solely to a higher mean value for glomerular
capillary hydraulic pressure (P0c). Because the
moderately hyperglycemic rats were in filtration
pressure disequilibrium with H less than P (P <
0.01), unique values for K1 were calculable. On av-
erage, the unique Kf was not significantly different
from the mean minimal value in the control group
and thus could not account for the higher SNGFR
with moderate hyperglycemia. Likewise, the slight-
ly higher values for CA and 11A in the moderately
hyperglycemic group would oppose filtration and
thus do not account for the increased SNGFR in
this group.
Calculated afferent and efferent arteriolar and to-
tal arteriolar resistances are summarized in Table 1.
The two groups of diabetic rats have contrasting
patterns of microvascular resistances. The severely
hyperglycemic animals demonstrated increases in
both afferent and efferent resistances as well as total
arteriolar resistance when compared with normal
rats. But, the moderately hyperglycemic group had
lower afferent and total resistances than did the nor-
mal controls, whereas the numerically lower mean
value of efferent artenolar resistance, RE, was not
statistically different from the control value. Thus,
there was a tendency for intrarenal vasoconstric-
tion in the severely hyperglycemic group but an
opposite tendency to vasodilatation in the moder-
ately hyperglycemic group.
Measurements of blood volume in a separate
group of 17 rats demonstrated equivalent absolute
blood volumes in these three metabolic states, with
values averaging 13.7 ± 1.0, 13.9 ± 0.6, and 15.7 ±
1.0 mllrat in normal, severely, and moderately hy-
perglycemic rats, respectively. These absolute val-
ues did not differ from one another statistically.
When factored by mean body weight, however,
blood volumes averaged 4.2 ± 0.2, 5.8 ± 0.3, and
5.5 ± 0.4 ml per 100 g in the same three groups, with
the latter two values being significantly higher (P <
0.05) than control but not significantly different
from one another.
Discussion
In severely hyperglycemic diabetic rats, SNGFR
and GFR values fell below control levels because of
the lower mean value for glomerular plasma flow
rate (QA). With moderate hyperglycemia, achieved
by chronic low dose insulin administration, hyper-
filtration occurred due to elevations of both QA and
iSP. Of note, these changes in glomerular dynamics
occurred at a stage in this experimental model of
diabetes when glomerular structural lesions have
been shown to be absent [13].
These findings are therefore in keeping with the
clinical observation that GFR tends to be reduced in
patients with severe uncontrolled hyperglycemia
(diabetic keto-acidosis or hyperglycemic nonketotic
coma), whereas hyperfiltration is usually found in
human diabetics when blood glucose concentra-
tions are elevated to a lesser degree [1, 2]. The re-
versible decline in GFR seen in patients with diabet-
ic keto-acidosis is usually accompanied by a fall in



















ni/(sec mm Hg)X 1010 dynes sec cm5
5.4 8.3 17.6 33.6 0.35 48.9 1.10 0.97 142 3.0 2.1 5.0 >0.095
±0.3 ±0.1 ±0.4 ±0.9 ±0.01 ±3.8 ±0.06 ±0.05 ±11 ±0.3 ±0.2 ±0.4 ±0.013
5.2 8.1 15.4 32.2 0.35 28.8 0.76 0.61 86 4.7 3.5 8.4 >0.048
±0.2 ±0.4 ±1.7 ±2.5 ±0.02 ±1.9 ±0.03 ±0.05 ±8 ±0.6 ±0.2 ±0.8 ±0.010
6.0 8.5 20.2 35.1 0.30 69.0 1.47 0.99 240 1.9 1.6 3.5 0.080
±0.2 ±0.1 ±0.9 ±1.0 ±0.02 ±8.0 ±0.13 ±0.08 ±34 ±0.3 ±0.3 ±0.7 ±0.015
NS NS NS NS NS <0.001 <0.001 <0.001 <0.005 <0.025 <0.001 <0.005
<0.02 NS <0.02 NS NS <0.001 <0.001 <0.005 <0.005 <0.005 <0.001 <0.001
<0.02 NS <0.02 NS NS <0.05 <0.02 NS <0.01 <0.01 NS <0.05 NS
renal plasma flow and depletion of extracellular
fluid volume [2, 14]. With lesser degrees of hyper-
glycemia, however, extracellular volume tends to
expand, rather than contract, presumably because
the associated glycosuria and osmotic diuresis are
less profound than they are with severe hyper-
glycemia [15]. It has been suggested that these
changes in extracellular fluid volume underlie, at
least in part, the patterns of hyperfiltration and re-
duced filtration seen in these two groups of diabetic
human subjects [15].
Not all investigators have found an increase in
plasma volume in moderately hyperglycemic dia-
betics when compared with normal subjects [16].
Further, elevation of blood glucose levels achieved
by glucose loading in normal subjects has led to an
increase in GFR but not of the same degree as com-
parable hyperglycemia in diabetics. This implies
that factors in addition to glucose level (and thereby
changes in plasma volume) may effect the changes
in GFR [15]. The results of blood volume measure-
ments in the present study suggest that neither ab-
solute nor relative blood volume contraction alone
may be invoked as the cause for the reduced GFR
and SNGFR in the severely hyperglycemic rats.
Indeed both groups of hyperglycemic rats had sig-
nificantly greater blood volumes per unit of body
weight than did controls, whereas SNGFR was re-
duced in severely hyperglycemic rats but increased
in rats with more moderate hyperglycemia. The
tendency for increased plasma volume has also
been demonstrated in alloxan diabetic rats with a
mean blood glucose of 616 mgldl [12]. Thus, the
differences in SNGFR in our two groups of diabetic
rats appear not to be a simple consequence of dif-
ferences in circulating blood volume. More insight
is gained, however, when these changes in volume
are considered in the context of the intrarenal micro-
vascular resistances that characterize each of the
hyperglycemic groups in the present study. Thus,
the high relative blood volume, together with the
low values for RA and RE, made possible the striking
elevations in QA and SNGFR measured in the mod-
erately hyperglycemic group. By contrast, despite
equivalent elevations in relative blood volume in
the severely hyperglycemic group, marked in-
creases in RA and RE were present. Therefore, QA
and SNGFR were lower than control in this group.
In other words, despite the relative blood volume
expansion in the severely hyperglycemic group, in-
tense renal vasoconstriction prevented the increases
in QA and SNGFR seen with more moderate hy-
perglycemia.
Studies of clinical and experimental diabetes
have demonstrated that renal size increases early in
this condition, and the increased size is by some un-
known mechanism related to the degree of metabol-
ic control and can be reversed with rigorous insulin
therapy [1, 17]. Glomerular dimensions also change
relatively early in experimental diabetes [18]. Thus,
it is possible that the greater weight of the kidneys
in the moderately hyperglycemic group may ac-
count in part for the greater filtration rates. The
finding that GFR per gram of kidney weight did not
increase in the moderately hyperglycemic animals
is consistent with such a possibility. But changes in
kidney weight alone do not explain all the results
because severely hyperglycemic rats had kidney
weights that were not statistically significantly dif-
ferent from normal animals, yet these animals nev-
ertheless demonstrated lower than normal filtration
rates.
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An increase in glomerular capillary surface area
has been estimated from morphometric analyses of
renal biopsy specimens in diabetic subjects, and
this increased surface area has also been proposed
to account for the hyperfiltration observed in dia-
betic subjects [1, 18]. Even if similar increases in
glomerular capillary surface area were present in
our rats, this would fail to account for measured dif-
ferences in GFR and SNGFR between severely
and moderately hyperglycemic animals because
Kf values were not altered to an important physi-
ologic extent in either group. Rather, the finding
in moderately hyperglycemic rats of elevations
in QA and zP more readily account for the observed
increments in GFR and SNGFR in this group,
whereas in severely hyperglycemic rats the decline
in QA constitutes the main factor responsible for the
measured falls in SNGFR and GFR.
It is possible that one or more hormonal systems
are responsible for the observed resetting of the gb-
merular pressures and flows in diabetic rats. Gluca-
gon and growth hormone are both present in in-
creased concentrations in the plasma of poorly con-
trolled diabetic subjects, and both hormones are
capable of increasing GFR [20-231. Insulin may also
play a role in that this hormone has been shown to
reduce GFR acutely in uncontrolled diabetics and
to be capable of binding to specific receptors in iso-
lated glomeruli [22, 24, 25]. In this regard, it is pos-
sible that the low dose of insulin used to produce
moderate hyperglycemia may have altered the gb-
merular hemodynamics by some means independ-
ent of its effect on blood glucose. Of note, the dia-
betic state has also been shown to be associated
with alterations in vascular responsiveness to such
potent vasoactive substances as angiotensin II and
catecholamines, humoral agents capable of initiat-
ing profound alterations in glomerular micro-
circulatory dynamics [12, 26, 27]. Similarly, prosta-
glandins and other endogenous vasodilators have
been shown to exert dramatic influences on gb-
merular hemodynamics [6]. Of interest are the find-
ings that prostaglandin production is increased in
platelets of diabetic patients and that the renal me-
dulla exposed to varying glucose concentrations in
vitro alters its production of these local vasodilators
[28, 29]. Additional studies are therefore required to
ascertain whether these or other humoral agents are
responsible for the striking alterations in glomerular
hemodynamics observed in diabetic rats. Likewise,
whether chronic modifications of these humoral re-
sponses influence the onset and progression of the
structural damage known to underlie the nephropa-
thy that develops in this common metabolic dis-
order in man remains an important issue to resolve.
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